Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Aug;87(15):5744–5748. doi: 10.1073/pnas.87.15.5744

Lipid composition is important for highly efficient target binding and retention of immunoliposomes.

K Maruyama 1, S J Kennel 1, L Huang 1
PMCID: PMC54404  PMID: 2377612

Abstract

By taking advantage of a monoclonal IgG antibody, 34A, which is highly specific to pulmonary endothelial cells, we have prepared liposomes containing various amounts of antibody molecules (immunoliposomes). These immunoliposomes accumulate specifically in the lung when injected i.v. Two lipid compositions were used: phosphatidylcholine/cholesterol/phosphatidylserine (PS), 10:5:1 (mol/mol), a composition that allows liposomes to be readily taken up by the reticuloendothelial system (RES) (liver and spleen), and phosphatidylcholine/cholesterol/ganglioside GM1, 10:5:1 (mol/mol), a composition that allows liposomes to avoid or delay the RES uptake (the so-called stealth liposomes). Although an increase in the number of antibody molecules per liposome was accompanied by an increased level of lung binding of the immunoliposomes, differences due to the lipid composition were more profound. For example, stealth immunoliposomes containing an antibody/lipid ratio = 1:37 (wt/wt) accumulated in lung to a level of 60% of the injected dose, whereas PS-containing immunoliposomes with a higher antibody/lipid ratio (1:8) only accumulated 50% of the injected dose in the lung. Conjugation of antibody to the stealth liposome did not increase the rate of liposome uptake by liver; this rate was approximately 10-fold lower than that of the PS-containing liposomes without antibody. Stealth immunoliposomes with high antibody content also showed long retention in the lung. The t1/2 of lung residence for the stealth immunoliposomes with an antibody/lipid ratio = 1:11 (wt/wt) was approximately 24 hr. The fact that stealth immunoliposomes showed a longer retention time in the lung than the PS-containing immunoliposomes of similar antibody content suggests that macrophages may play a role in the removal of the bound immunoliposomes from the pulmonary endothelium. Alternatively, dissociated stealth immunoliposomes may reenter the circulation and rebind to the lung target, causing an apparent slow overall dissociation rate. These results can be understood on the basis of two competing kinetic processes: lung binding whose rate is directly proportional to the antibody content of the immunoliposomes and uptake by RES whose rate is significantly reduced in the case of the stealth liposomes. Even for a modest level of antibody content, the half-life for target binding of immunoliposomes was significantly shorter than the half-life of liver uptake of the liposomes, resulting in a favorable target binding. Significant immunoliposome binding to the lung is not due to the fact that tail vein-injected liposomes flow through the lung capillary bed before they encounter the liver, because portal vein-injected immunoliposomes showed the same rate and extent of target binding as the tail vein-injected ones.

Full text

PDF
5744

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen T. M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 1987 Oct 19;223(1):42–46. doi: 10.1016/0014-5793(87)80506-9. [DOI] [PubMed] [Google Scholar]
  2. Allen T. M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta. 1989 May 19;981(1):27–35. doi: 10.1016/0005-2736(89)90078-3. [DOI] [PubMed] [Google Scholar]
  3. Allen T. M., Williamson P., Schlegel R. A. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8067–8071. doi: 10.1073/pnas.85.21.8067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aragnol D., Leserman L. D. Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2699–2703. doi: 10.1073/pnas.83.8.2699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bell G. I. Models for the specific adhesion of cells to cells. Science. 1978 May 12;200(4342):618–627. doi: 10.1126/science.347575. [DOI] [PubMed] [Google Scholar]
  6. Connor J., Sullivan S., Huang L. Monoclonal antibody and liposomes. Pharmacol Ther. 1985;28(3):341–365. doi: 10.1016/0163-7258(85)90058-0. [DOI] [PubMed] [Google Scholar]
  7. Derksen J. T., Morselt H. W., Scherphof G. L. Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim Biophys Acta. 1988 Sep 16;971(2):127–136. doi: 10.1016/0167-4889(88)90184-x. [DOI] [PubMed] [Google Scholar]
  8. Enoch H. G., Strittmatter P. Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. Proc Natl Acad Sci U S A. 1979 Jan;76(1):145–149. doi: 10.1073/pnas.76.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6949–6953. doi: 10.1073/pnas.85.18.6949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ho R. J., Rouse B. T., Huang L. Target-sensitive immunoliposomes: preparation and characterization. Biochemistry. 1986 Sep 23;25(19):5500–5506. doi: 10.1021/bi00367a023. [DOI] [PubMed] [Google Scholar]
  11. Holmberg E., Maruyama K., Litzinger D. C., Wright S., Davis M., Kabalka G. W., Kennel S. J., Huang L. Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1272–1278. doi: 10.1016/0006-291x(89)92740-x. [DOI] [PubMed] [Google Scholar]
  12. Hughes B. J., Kennel S., Lee R., Huang L. Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res. 1989 Nov 15;49(22):6214–6220. [PubMed] [Google Scholar]
  13. Kabalka G., Buonocore E., Hubner K., Moss T., Norley N., Huang L. Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. Radiology. 1987 Apr;163(1):255–258. doi: 10.1148/radiology.163.1.3454163. [DOI] [PubMed] [Google Scholar]
  14. Kennel S. J., Lankford T., Hughes B., Hotchkiss J. A. Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay. Lab Invest. 1988 Nov;59(5):692–701. [PubMed] [Google Scholar]
  15. Liu D., Huang L. pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation. Biochim Biophys Acta. 1990 Mar;1022(3):348–354. doi: 10.1016/0005-2736(90)90284-u. [DOI] [PubMed] [Google Scholar]
  16. Papahadjopoulos D., Gabizon A. Targeting of liposomes to tumor cells in vivo. Ann N Y Acad Sci. 1987;507:64–74. doi: 10.1111/j.1749-6632.1987.tb45792.x. [DOI] [PubMed] [Google Scholar]
  17. Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., Fidler I. J. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res. 1982 Apr;42(4):1412–1422. [PubMed] [Google Scholar]
  18. Raz A., Bucana C., Fogler W. E., Poste G., Fidler I. J. Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res. 1981 Feb;41(2):487–494. [PubMed] [Google Scholar]
  19. Rorvik M. C., Allison D. P., Hotchkiss J. A., Witschi H. P., Kennel S. J. Antibodies to mouse lung capillary endothelium. J Histochem Cytochem. 1988 Jul;36(7):741–749. doi: 10.1177/36.7.3290332. [DOI] [PubMed] [Google Scholar]
  20. Senior J. H. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst. 1987;3(2):123–193. [PubMed] [Google Scholar]
  21. Torchilin V. P. Liposomes as targetable drug carriers. Crit Rev Ther Drug Carrier Syst. 1985;2(1):65–115. [PubMed] [Google Scholar]
  22. Weissig V., Lasch J., Klibanov A. L., Torchilin V. P. A new hydrophobic anchor for the attachment of proteins to liposomal membranes. FEBS Lett. 1986 Jun 23;202(1):86–90. doi: 10.1016/0014-5793(86)80654-8. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES